Cure for Peritoneal Metastases? An Evidence-Based Review
This review critically evaluates the current body of published evidence for the use of CS/HIPEC in the treatment of advanced colorectal, appendiceal and gastric cancer.
Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Sarcomatosis
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is the treatment most likely to achieve prolonged survival for peritoneal surface disease from various primaries, yet management of peritoneal sarcomatosis is controversial as a result of the propensity of sarcomas for hematogenous spread and the paucity of effective chemotherapy. Therefore, we reviewed our experience in patients with sarcomatosis.
Assessment of Clinical Benefit and Quality of Life in Patients Undergoing Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Management of Peritoneal Metastases
This review summarizes the published data related to outcome and quality of life after cytoreduction and HIPEC to provide insights into its use in patients with peritoneal carcinomatosis.
Current Management of Peritoneal Carcinomatosis from Colorectal Cancer
HIPEC has been shown to significantly reduce the risk of peritoneal recurrence. Cytoreduction and HIPEC should be a component of a multimodal approach, including neoadjuvant and adjuvant therapeutic regimens.
New Technologies in Coronary Artery Surgery
The current review explores the use of new technologies and future directions in coronary artery surgery, through 1) stressing the importance of multiple arterial conduits and especially the use of bilateral mammary artery; 2) discussing the advantages and disadvantages of off-pump coronary artery bypass; 3) presenting additional techniques, e.g. minimally invasive direct coronary artery bypass grafting, hybrid, and robotic-assisted CABG; and, finally, 4) debating a novel external stenting technique for saphenous vein grafts.
Mitral Transcatheter Technologies
Mitral valve regurgitation (MR) is often diagnosed in patients with heart failure and is associated with worsening of symptoms and reduced survival.
Robotics in Cardiac Surgery: Past, Present, and Future
The history and evolution of these procedures, as well as the present status and future directions of robotic cardiac surgery, are presented in this review.
New Technologies and Hybrid Surgery for Atrial Fibrillation
This article provides our experience and an overview of the current knowledge in the hybrid treatment of stand-alone atrial fibrillation.
Multi-modality Imaging of the Aortic Valve in the Era of Transcatheter Aortic Valve Replacement: a Guide for Patient Selection, Valve Selection, and Valve Delivery
This paper will review the role of various imaging modalities during the phases of the TAVR procedure with an emphasis on the advantages and limitations of each approach.
Fresenius Kabi USA Initiates Voluntary Recall of Single Lot of Magnesium Sulfate
FOR IMMEDIATE RELEASE - May 25, 2013 - Fresenius Kabi USA announced today it has initiated a voluntary recall of one lot – Lot 6103882 – of Magnesium Sulfate Injection, USP due to the potential presence of glass particles in the vials. The recall is a precautionary measure, following a routine company inspection of retained product samples.
A Practical Guide to the Use of Echocardiography in Assisting Structural Heart Disease Interventions
This article provides a practical guide for using echocardiography in common interventional procedures, including percutaneous atrial septal defect closure, transcatheter aortic valve replacement, percutaneous repair of prosthetic valve paravalvular leaks, percutaneous mitral valve edge-to-edge repair, and percutaneous placement of appendage occlusion devices.
Transcatheter Aortic Valve Replacement with CoreValve
The CoreValve is just completing clinical trial in the United States and not yet available for commercial use in the United States but is widely used in Europe.